SIV's natural hosts reveal how humans might better manage HIV infection

March 8, 2012 in HIV & AIDS

Some monkeys can survive infection by SIV, a relative of HIV, and not develop AIDS. Their immune systems appear to display a pattern of "peaceful coexistence" rather than the all-out conflict provoked by HIV when it infects humans.

SIV's natural hosts are non-human primates found in , including sooty mangabeys and African green monkeys – both species whose infections have been studied in captivity -- as well as other species such as mandrills, drills and suntailed monkeys.

Since SIV's natural hosts have adapted to manage infection rather than fight and lose, we have much to learn from them, a team of scientists from Yerkes National Primate Research Center propose in an article published this week in Science.

Studying how SIV and its natural hosts co-exist could show medical researchers how to improve long-term care for people infected with and reduce mother-to-infant transmission, as well as guide the development of an AIDS vaccine, the researchers write.

The authors include Ann Chahroudi, Steven Bosinger, Thomas Vanderford, Mirko Paiardini and Guido Silvestri. Silvestri is chief of microbiology and immunology at Yerkes and a Georgia Research Alliance Eminent Scholar.

Together with NIH researcher Nichole Klatt, Silvestri is also author of a recent Perspective piece in Science Translational Medicine about the role of CD4+ T cells in HIV infection.

In their review, the scientists call SIV's natural hosts "the door through which HIV came to humans." Genetic analysis has shown that HIV infection of humans arose through multiple cross-species transmissions of SIV from non-human primates.

Distinctive features of SIV natural host infection include a low level of immune activation and a low rate of mother-to-infant transmission, compared to humans. This reflects evolutionary history during the last several thousand years, the authors propose.

"In this view, the genetic features of natural SIV hosts that underlie two key mechanisms of resistance (i.e. low immune activation and target cell restriction) may at least partially reflect evolutionary selection to protect from mother-to-infant transmission," they write.

Researchers have observed that a small number of HIV-infected people exhibit a "natural host-like" phenotype, where low levels of immune activation are seen. In most humans, HIV infection leads to chronic immune activation, which causes health problems even in people who receive long-term antiretroviral treatment.

During infection, SIV's natural hosts also manage to preserve particular types of immune cells including Th17 cells, which help maintain the intestines, and central memory T cells, important for keeping the immune system's ability to respond to previously encountered bacteria or viruses.

Understanding how SIV's natural hosts avoid chronic and preserve immune function could help improve medical care for people living with HIV , the authors conclude.

Journal reference: Science Translational Medicine search and more info website

Provided by Emory University search and more info website

4.5 /5 (2 votes)  

Rank 4.5 /5 (2 votes)
Relevant PhysicsForums posts

More news stories

Integrating mental health care into HIV care

The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...

HIV & AIDS created 8 hours ago | popularity not rated yet | comments 0

After a decade, global AIDS program looks ahead

(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...

HIV & AIDS created 20 hours ago | popularity not rated yet | comments 0

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

HIV & AIDS created May 19, 2013 | popularity 5 / 5 (1) | comments 0

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

HIV & AIDS created May 18, 2013 | popularity 5 / 5 (2) | comments 0

Peer-referral programs can increase HIV-testing in emergency departments

Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...

HIV & AIDS created May 17, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.